Endocrinology, Vol 130, 3283-3288, Copyright © 1992 by Endocrine Society

ARTICLES

Exogenously administered testosterone maintains spermatogenesis quantitatively in adult rats actively immunized against gonadotropin- releasing hormone

CA Awoniyi, BR Zirkin, V Chandrashekar and WD Schlaff
Department of Obstetrics and Gynecology, University of Colorado Health Sciences Center, Denver 80262.

The administration of testosterone via Silastic capsules has been shown previously to maintain advanced spermatid number quantitatively in intact rats in which LH but not FSH was suppressed, but not in hypophysectomized rats, indicating that pituitary factors in addition to LH are required for the quantitative maintenance of spermatogenesis in the rat. The objective of the present study was to examine whether testosterone is capable of maintaining quantitatively normal spermatogenesis in rats in which both LH and FSH are suppressed. Intact adult male rats were actively immunized against GnRH by intradermal injection of GnRH conjugated to human serum globulin; control rats received intradermal injections of saline and adjuvant. Four weeks after the primary immunization, GnRH-immunized rats received the first booster injection and, at the same time, received testosterone-filled polydimethylsiloxane (PDS) implants of 4, 8, 12, or 24 cm or empty implants. Booster injections were repeated every 2 weeks for 8 weeks. At that time, rats were killed, and serum levels of LH, FSH, and testosterone, testicular advanced spermatid number, and seminiferous tubule fluid testosterone concentrations were determined. Four weeks after the initial administration of GnRH immunogen, i.e. before the first booster injection, serum levels of testosterone, LH, and FSH and the number of advanced spermatids per testis were not different from those in controls. Eight weeks after the first booster injection, serum LH and FSH and advanced spermatids were undetectable in all GnRH- immunized rats. The administration of testosterone-filled PDS implants of 4 and 8 cm to GnRH-immunized rats for 8 weeks resulted in the maintenance of 105 +/- 6 and 161 +/- 5 x 10(6) advanced spermatid/testis, respectively, significantly less than the control value (237 +/- 19 x 10(6)). In GnRH-immunized rats that received testosterone-filled PDS implants of 12 or 24 cm, the advanced spermatid numbers per testis (228 +/- 4 and 229 +/- 8 x 10(6), respectively) were not significantly different from those in controls. These results indicate that testosterone is capable of maintaining spermatogenesis quantitatively in the adult rats testis, in the absence of both radioimmunoassayable LH and FSH.

This article has been cited by other articles:

				A. Jones, J. Chen, D. J. Hwang, D. D. Miller, and J. T. Dalton Preclinical Characterization of a (S)-N-(4-Cyano-3-Trifluoromethyl-Phenyl)-3-(3-Fluoro, 4-Chlorophenoxy)-2-Hydroxy-2-Methyl-Propanamide: A Selective Androgen Receptor Modulator for Hormonal Male Contraception Endocrinology, January 1, 2009; 150(1): 385 - 395. [Abstract] [Full Text] [PDF]

				S. T. Page, T. F. Kalhorn, W. J. Bremner, B. D. Anawalt, A. M. Matsumoto, and J. K. Amory Intratesticular Androgens and Spermatogenesis During Severe Gonadotropin Suppression Induced by Male Hormonal Contraceptive Treatment J Androl, September 1, 2007; 28(5): 734 - 741. [Abstract] [Full Text] [PDF]

				S. J Meachem, D. M Robertson, N. G Wreford, R. I McLachlan, and P. G Stanton Oestrogen does not affect the restoration of spermatogenesis in the gonadotrophin-releasing hormone-immunised adult rat J. Endocrinol., June 1, 2005; 185(3): 529 - 538. [Abstract] [Full Text] [PDF]

				A. D. Coviello, W. J. Bremner, A. M. Matsumoto, K. L. Herbst, J. K. Amory, B. D. Anawalt, X. Yan, T. R. Brown, W. W. Wright, B. R. Zirkin, et al. Intratesticular Testosterone Concentrations Comparable With Serum Levels Are Not Sufficient to Maintain Normal Sperm Production in Men Receiving a Hormonal Contraceptive Regimen J Androl, November 1, 2004; 25(6): 931 - 938. [Abstract] [Full Text] [PDF]

				R. I. McLachlan, D. M. Robertson, E. Pruysers, A. Ugoni, A. M. Matsumoto, B. D. Anawalt, W. J. Bremner, and C. Meriggiola Relationship between Serum Gonadotropins and Spermatogenic Suppression in Men Undergoing Steroidal Contraceptive Treatment J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 142 - 149. [Abstract] [Full Text] [PDF]

				T. Yazawa, T. Yamamoto, Y. Jin, and S.-i. Abe Follicle-Stimulating Hormone Is Indispensable for the Last Spermatogonial Mitosis Preceding Meiosis Initiation in Newts (Cynops pyrrhogaster) Biol Reprod, January 1, 2002; 66(1): 14 - 20. [Abstract] [Full Text]

				N. Kumar, T. Savage, W. DeJesus, Y. Y. Tsong, A. Didolkar, and K. Sundaram Chronic Toxicity and Reversibility of Antifertility Effect of Immunization against Gonadotropin-Releasing Hormone in Male Rats and Rabbits Toxicol. Sci., January 1, 2000; 53(1): 92 - 92. [Abstract] [Full Text] [PDF]

				E. Zanella, D. Lunstra, T. Wise, J. Kinder, and J. Ford Testicular Morphology and Function in Boars Differing in Concentrations of Plasma Follicle-Stimulating Hormone Biol Reprod, January 1, 1999; 60(1): 115 - 118. [Abstract] [Full Text]

				J. Tesarik, M. Guido, C. Mendoza, and E. Greco Human Spermatogenesis in Vitro: Respective Effects of Follicle-Stimulating Hormone and Testosterone on Meiosis, Spermiogenesis, and Sertoli Cell Apoptosis J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4467 - 4473. [Abstract] [Full Text]